Purpose of review Dysregulated citrullination is a key element that drives the production and maintenance of antibodies to citrullinated proteins, a hallmark in rheumatoid arthritis (RA). This article reviews recent literature on the origin of citrullinated antigens in RA.
INTRODUCTION
The nonessential amino acid citrulline was isolated from the juice of the watermelon, Citrullus vulgaris, by Koga and Ohtake in 1914 [1] . Wada established the structure of citrulline in 1930 and provided the first evidence that this amino acid can be found in proteins [2, 3] . Further studies by Rogers et al. demonstrated that citrulline was enzymatically generated by side-chain conversion of peptidylarginine to peptidylcitrulline in a calcium-dependent process known as deimination or citrullination [4] [5] [6] . The enzyme responsible for this reaction was partially purified by Fujisaki and Sugawara in 1981 and named peptidylarginine deiminase (PAD) [7] . Five PADs have since been identified in humans (PAD1-4 and 6) [8] [9] [10] [11] [12] [13] and are located in a cluster on chromosome 1p36.1 [12] . While the discovery of citrullination generated interest in different areas of research, the finding by Schellekens et al. that citrullinated proteins are major targets of antibodies in patients with rheumatoid arthritis (RA) [14] sparked major interest in understanding the role of citrullination in RA pathogenesis. Here, we discuss the most recent evidence regarding the causes and significance of dysregulated production of citrullinated proteins in RA, collectively referred to as the RA citrullinome.
MECHANISMS THAT REGULATE PHYSIOLOGIC CITRULLINATION
In order to discuss pathways that may lead to dysregulated protein citrullination in RA, it is important to first review what is known about the physiologic mechanisms regulating protein citrullination and the significant gaps in knowledge that still exist. In contrast to many other posttranslational modifications (PTM), citrullination appears to be an irreversible process. 'De-citrullinating' enzymes that convert citrullinated proteins back to their native peptidylarginine containing forms have not been discovered. The mechanisms involved in the clearance or turnover of citrullinated proteins in cells also remain unknown. As citrullination reduces the net charge of proteins through the loss of one positive charge per modified arginine residue, it can increase protein hydrophobicity, lead to protein unfolding, and alter intra-and intermolecular interactions [15] . These structural changes can lead to either gain or more likely, loss of protein function [15] [16] [17] [18] [19] [20] [21] . Given that citrullination can have important and potentially irreversible consequences on protein function, the role of citrullination as a mechanism to control cellular processes must be tightly regulated to avoid excessive citrullination of physiologic targets or citrullination of nonphysiologic substrates.
One component that controls PAD activation is calcium [6, 7] . Binding to calcium induces conformational changes that generate the active form of the enzymes [22] . While full activation of PADs requires millimolar amounts of calcium in vitro [7, 23] , PAD activation in cells is observed under physiologic conditions where intracellular calcium does not exceed nanomolar concentrations [19, [24] [25] [26] [27] . It is possible that these suboptimal calcium concentrations induce a PAD conformation that selects for only high efficiency substrates, thereby limiting aberrant citrullination events. Additionally, it is suspected that intracellular protein cofactors may be responsible for modulating calcium sensitivity and specificity of the PAD enzymes, but such binding partners have not been identified. Considering the importance of calcium in PAD activation, pathways that dysregulate calcium binding to PADs (as discussed below) are likely relevant to RA pathogenesis.
Another important component for efficient PAD activity is the presence of a reducing environment [6, 7] , which is necessary to maintain the active site free thiol cysteine required for catalysis [28] . A recent study found that synovial fluid is unable to sustain PAD activity unless reducing agents, such as dithiothreitol or reduced glutathione, were present [29] . The oxidizing nature of the extracellular environment, which contrasts with the reducing environment inside cells [30] , may therefore provide the conditions needed to protect against aberrant extracellular citrullination by PADs that may leak from activated or dying cells. The importance of reactive oxygen species (ROS) in controlling PAD activity has been recently underscored by the finding that ROS generated by NADPH oxidase inhibits the catalytic activity of PAD2 and PAD4 [31 && ]. The activation of NADPH oxidase as a mechanism to limit PAD activation may play an important role in preventing hypercitrullination during neutrophil extracellular trap (NET) formation [32] , in which citrullination may have deleterious effects on the antimicrobial activity of NETs [33 && ].
DEFINING THE RHEUMATOID ARTHRITIS CITRULLINOME
A key sustaining component in autoimmune rheumatic diseases is the autoantigen, which fuels the ongoing immune response. Synovial fluid from patients with RA contains a unique pattern of citrullination that includes proteins spanning the range of molecular weights, termed hypercitrullination [34] . Proteomic analysis of the cellular and soluble components in RA synovial fluid have identified more than 100 citrullinated proteins [35] [36] [37] , which include both intra-and extracellular substrates and together comprises RA citrullinome. The significance of this citrullinome to RA pathogenesis and the generation of anticitrullinated protein antibodies (ACPAs), however, are not fully understood.
KEY POINTS
The RA citrullinome comprises a unique set of intra-and extracellular citrullinated proteins that are highly enriched in the rheumatoid joint. The abnormal accumulation of citrullinated proteins suggests that mechanisms controlling citrullination are dysregulated in RA.
Calcium and reducing conditions are necessary for efficient PAD activation. Oxidizing environments inhibit PAD activity.
Pathways that promote suprathreshold amounts of intracellular calcium, such as host (i.e., perforin and membrane attack complex) and bacterial (i.e., toxins) pore-forming proteins, are potent activators of PADs and inducers of hypercitrullination.
Bacterial and host pore-forming pathways likely sustain citrullinated autoantigen production at extraarticular sites of disease initiation and in the RA joint, respectively.
As PADs are oxidized and inactivated extracellularly, efficient extracellular citrullination in RA likely requires PAD activating cofactors (e.g. anti-PAD activating antibodies) and the continual release of active PAD enzymes from dying and activated cells.
Despite the considerable number of citrullinated proteins found in RA synovial fluid, only few have been identified as being targets of ACPAs (e.g., vimentin, a-enolase, and fibrinogen). Whether unique ACPAs exist for each protein in the RA citrullinome or whether only few citrullinated proteins drive the complete ACPA response is still unknown. Given that citrullination is a physiologic process, it is unclear why this PTM becomes a target of an abnormal immune response in RA.
Interestingly, while citrullination is clearly an important process for the physiologic function of proteins, such as trichohyalin, filaggrin, histones, and transcription factors [6, 24, 26, 27, [38] [39] [40] [41] [42] [43] [44] [45] , it is unknown whether the majority of proteins that comprises the RA citrullinome are physiologic or accidental pathologic targets of PADs. In the case of well-defined citrullinated autoantigens like a-enolase and vimentin, for example, hypercitrullination in vitro inactivates their function [16, 20] . However, it is unknown whether this modification is part of the normal regulation of these proteins or only occurs in pathologic conditions.
If nonselective citrullination occurs accidentally as a consequence of uncontrolled PAD activation, it may lead to the generation of neocitrullinated proteins not previously tolerized by the immune system and consequently trigger an autoimmune response in susceptible individuals. Alternatively, it is possible that hyperactivation of PADs may accidentally target novel sites in proteins, generating nontolerized neoepitopes in abnormally hypercitrullinated molecules. In this regard, recent work demonstrated that while fibrinogen is more extensively citrullinated by PAD2 compared with PAD4 [46] , distinct partially citrullinated forms of fibrinogen induced by PAD4 are preferentially recognized by ACPAs [47 & ]. This supports the hypothesis that the generation of unique citrullination sites in proteins may drive their immunogenicity. The production of neocitrullinated proteins or epitopes may occur and propagate specifically in RA target tissues, such as the joints, due to the establishment of amplification cycles in which damage to PAD-expressing cells by immune components leads to further hypercitrullination (discussed below). This may explain why other tissues highly enriched with physiologically citrullinated proteins, such as the skin, are not pathologic targets for ACPAs.
THE ORIGIN OF THE RHEUMATOID ARTHRITIS CITRULLINOME
The RA citrullinome is comprised of intra-and extracellular proteins, suggesting that PADs are dysregulated in both compartments. Any PADexpressing cell present in the RA joint could contribute to the RA citrullinome, including immune cells and resident fibroblast-like synoviocytes (FLSs) [48, 49] . Recent studies have revealed neutrophils, the most abundant immune cells in RA synovial fluid [50] , as major sources of intracellular citrullination and soluble PADs for extracellular citrullination [34, 51, 52 && ,53]. FLSs and monocytes have also been shown to generate citrullinated a-enolase and vimentin, known RA autoantigens, following treatment with specific stimuli [54, 55] . Mechanisms implicated in generating the RA citrullinome will be discussed in detail below.
MEMBRANOLYTIC PATHWAYS AS DRIVERS OF THE INTRACELLULAR RHEUMATOID ARTHRITIS CITRULLINOME
The finding that cells in RA synovial fluid have marked citrullination has focused attention on understanding mechanisms of hypercitrullination that can reproduce the RA citrullinome. Analysis of a broad range of stimuli that induce neutrophil activation and death identified that perforin and the membrane attack complex (MAC), two immunemediated membranolytic pathways, have the unique capacity to reproduce similar patterns of hypercitrullination observed in RA synovial fluid [34] . Perforin and MAC are pore-forming cytolytic proteins that induced the influx of ions, particularly calcium, and osmotic lysis [56] [57] [58] . The form of cell death induced in neutrophils by these pore-forming mechanisms has recently been named leukotoxic hypercitrullination (LTH), to distinguish it from other forms of neutrophil death that do not induce hypercitrullination [33 && ]. However, even nonlethal amounts of perforin and MAC can lead to significant increases of intracellular calcium to the micromolar range [59, 60] , so may also support hypercitrullination. The abrupt and prominent influx of calcium resulting from pore-induced membranolytic damage likely overcomes regulatory pathways that control PAD activation in cells, leading to hyperactivation of the enzymes and subsequent hypercitrullination.
The ability to trigger calcium flux-induced LTH is not only limited to host immune pore-forming pathways, but also includes bacterial products such as calcium ionophores (i.e., ionomycin and calcimycin from Streptomyces species) and pore-forming toxins [33
&& ]. In this regard, the tantalizing idea that periodontal disease may initiate RA has been recently strengthened by the finding that the periodontal pathogen Aggregatibacter actinomycetemcomitans activates cellular hypercitrullination in neutrophils [52 && ] via secretion of the pore-forming protein leukotoxin A (LtxA). Like host pore-forming proteins, LtxA induces target cell death by membrane destabilization, influx of extracellular calcium, and osmotic lysis [61, 62] . Importantly, both the citrullinome induced by LtxA and the citrullinome present in the periodontium in periodontal disease have high similarity to the citrullinome found RA synovial fluid [52 && ]. Remarkably, the association of ACPAs with human leukocyte antigen-DRB1 alleles linked to RA appears to be significant only in patients with RA that had evidence of a history of infection with leukotoxic strains of A. actinomycetemcomitans [52 && ], as measured by the presence of antibodies to LtxA. This suggests that A. actinomycetemcomitans may play a role in ACPA development in individuals with a genetic predisposition to develop RA.
Interestingly, bacteria that colonize and infect other mucosal surfaces implicated in RA, such as the lung, gut, and urothelium [63, 64] , also rely on the production of pore-forming toxins as virulence factors to target neutrophils [65] [66] [67] . Initial characterization of some of these toxins has confirmed that other pathogenic bacteria, such as Staphylococcus aureus (via Panton-Valentine leukocidin), also have the capacity to induce neutrophil hypercitrullination [33 && ]. This suggests that membranolytic damage induced by several different bacterial pathobionts may stimulate chronic hypercitrullination in neutrophils, ACPA production, and RA development in susceptible individuals. Once an ACPA response is initiated at an extraarticular site against bacterial toxin-induced hypercitrullination, host pore-forming pathways (i.e., perforin and MAC) may be responsible for sustaining antigen production in the RA joints. In this scenario, bacteria may be necessary for disease initiation, but may not be required to sustain ongoing immune-mediated damage in the articular compartment.
CELL DEATH PATHWAYS AS DRIVERS OF THE INTRA-AND EXTRACELLULAR RHEUMATOID ARTHRITIS CITRULLINOME
Several mechanisms of cell death have been implicated in generating citrullinated autoantigens in RA, including autophagy, NETosis, necrosis, and more recently LTH (discussed in detail above). These forms of cell death could induce intracellular PAD activation and de-novo citrullinated protein generation, as well as the release of transiently active PADs into the extracellular environment [33 && ,53,54,68] . NETosis has gained attention as a mechanism to generate and release citrullinated autoantigens extracellularly, thereby triggering ACPA-associated experimental arthritis [68, 69] . Nevertheless, recent evidence has demonstrated that citrullination is not required for the formation of NETs (at least in human neutrophils) [32, 70, 71, 72] , bringing into question the role of NETs in the abnormal production of intracellular citrullinated autoantigens in RA. While some citrullinated proteins can be detected in NETs by mass spectrometry [53, 69] , it is noteworthy that several of these proteins (such as actin, histones, actin-related protein 2/3 complex subunit 1B, coronin, and leukocyte elastase inhibitor, among others) [53, 69] are also citrullinated in unstimulated neutrophils [34] . This raises the possibility that NETosis is only a redistributor of a limited steady state citrullinome in neutrophils, rather than a generator of de-novo pathogenic citrullination in RA.
Although autophagy does not induce hypercitrullination in neutrophils [34] , a recent study demonstrated that this programmed cell death mechanism does lead to the citrullination of aenolase and vimentin in monocytes and FLSs [54] . These citrullinated antigens are known targets of ACPAs and increased autophagy markers were reported to correlate with ACPA titers, suggesting that autophagy may contribute to generation of citrullinated proteins in patients with RA [54] .
While many forms of cell death may be responsible for releasing PADs extracellularly in RA, only NETosis and necrosis in neutrophils have been studied in detail [53] . Spontaneous release of nuclear material, described as NETosis, has been reported to occur in neutrophils from patients with RA, resulting in the extracellular release of PAD4 [73] , and increased nuclear material and PAD activity is present in the synovial fluid from patients with RA compared with osteoarthritis [53] . In in-vitro studies measuring extracellular PAD activity following cell death, significantly more active PAD enzyme was released following necrosis, compared with NETosis [53] . While the relative contributions of NETosis, necrosis, and other forms of cell death to extracellular PAD enzyme release in RA are unknown, these findings indicate that the release of extracellular PADs in RA is not representative of a single form of cell death.
AUTOANTIBODIES AS DRIVERS OF THE EXTRACELLULAR CITRULLINOME IN RHEUMATOID ARTHRITIS
Irrespective of the mechanism, increased soluble extracellular PAD2 and PAD4 is observed in the synovial fluid from patients with RA [53, 74] . Once released, these PADs have the potential to citrullinate extracellular substrates and interact with anti-PAD autoantibodies. Autoantibodies that enhance the catalytic activity of PAD4 by lowering the amount of calcium required for catalysis were recently described in RA [75] . These antibodies distinguish a unique subgroup of patients with the most erosive disease and pulmonary involvement [75] [76] [77] , supporting their potentially pathogenic role in RA. Interestingly, a recent study found that the oxidative environment in synovial fluid is unable to sustain PAD activity [29] . As PADs released from activated and dying neutrophils are transiently active [29] , it is possible that PAD4-activating antibodies may act by increasing PAD function despite the non-permissive conditions in synovial fluid, thus enhancing dysregulated extracellular citrullination.
Defining the citrullinated proteins generated in the presence of PAD4-activating antibodies will be important for understanding their contribution to the RA citrullinome.
CONCLUSION
The prominent accumulation of intra-and extracellular citrullinated proteins in the rheumatoid joint strongly suggests that citrullination is dysregulated in RA (Fig. 1) . The experimental replication of the cellular RA citrullinome requires stimuli that produce damage to the cell membrane, a prominent increase in intracellular calcium concentrations, and cytolysis (e.g., LTH). As such, pathobionts producing pore-forming proteins may be important in generating nontolerized neocitrullinated epitopes at extraarticular sites of disease initiation, including the mouth, gut, lungs and others (Fig. 1B) . Once tolerance is broken to the citrullinated products of bacterial-induced hypercitrullination, host poreforming proteins can sustain ongoing citrullinated autoantigen generation in the joints of patients with RA (Fig. 1C) . The production of the extracellular RA citrullinome likely requires a constant release of PADs from activated and dying cells, as well as the presence of cofactors that increase PAD activity (such as autoantibodies) to maintain efficient citrullination in the inhospitable oxidizing extracellular environment. Thus, inhibiting pathways that lead to PAD enzyme hyperactivation could suppress ongoing generation of the RA citrullinome and provide therapeutic benefit to patients with RA.
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